Metformin activates AMPK, a key regulator of cellular energy metabolism, and inhibits the AKT/mTOR pathway, resulting in reduced cancer cell growth and proliferation [8, 19, 20, 86, 87] (Fig. 3, Table 2). Here, AKT1 is linked to cancer.